TCL Archive GAO Probes NCI Intramural Program, Finds All Is Well, But Won’t Report It October 22, 1982
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005